Internal mammary artery graft function is not affected in hypertensive patients on therapy

Vascular

Volumn 5, Issue 4, 1997, Pages 367-375

  Deja, M A ^a   Golba, K S ^a   Wos, S ^a   Mrozek, R ^a   Bachowski, R ^a   Biernat, J ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

ACE inhibitors; calcium antagonists; endothelium derived relaxing factor; hypertension; internal mammary artery

Indexed keywords

ACETYLCHOLINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METOPROLOL; N(G) METHYLARGININE; NIFEDIPINE; NITRIC ACID DERIVATIVE; NORADRENALIN; POTASSIUM CHLORIDE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN TISSUE; HYPERTENSION; INTERNAL MAMMARY ARTERY; MALE; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; ENALAPRIL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MAMMARY ARTERIES; MIDDLE AGED; NITRIC OXIDE; VASOCONSTRICTION;

EID: 0031194855     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099700500405     Document Type: Article

References (42)

1. Cameron A., Davis K. B., Green G. E., Myers W. O., Pettinger M., Clinical implications of internal mammary artery bypass grafts: The Coronary Artery Surgery Study experience. Circulation, 1988, 77, 815–819.
2. Lehmann K. H., Von Segesser L., Müller-Glauser W., Siebenmann R., Schneider K., Lüschner T. F., Turina M., Internal-mammary coronary artery grafts: Is their superiority also due to a basically intact endothelium?. Thoracic and Cardiovascular Surgeon, 1989, 37, 187–189.
3. Chua Y. L., Pearson P. J., Evora P. R. B., Schaff H. V., Detection of intraluminal release of endothelium-derived relaxing factor from human saphenous veins. Circulation, 1993, 88 (Part 2), 128–132.
4. Lüscher T. F., Diederich D., Siebenmann R., Lehmann K., Stulz P., Von Segesser L., Yang Z., Turina M., Grädel E., Weber E., Bühler F. R., Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. New England Journal of Medicine, 1988, 319, 462–467.
5. Pearson P. J., Evora P. R. B., Schaff H. V., Bioassay of endothelium-derived relaxing factor from internal mammary arteries: Implication for early and late bypass graft patency. Annals of Thoracic Surgery, 1992, 54, 1078–1084.
6. Garg U. C., Hassid A., Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation, 1989, 83, 1774–1777.
7. Azuma H., Ishikawa M., Sekizaki S., Endothelium dependent inhibition of platelet aggregation. British Journal of Pharmacology, 1986, 88, 441–445.
8. Radomski M. W., Palmer R. M. J., Moncada S., Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet, 1987, 2, 1057–1058.
9. Radomski M. W., Palmer R. M. J., Moncada S., The anti-aggregating properties of vascular endothelium: Interaction between prostacyclin and nitric oxide. British Journal of Pharmacology, 1987, 92, 639–646.
10. Chesebro J. H., Clements I. P., Fuster V., et al, A-platlet-inhibitor-drug trial in coronary-artery bypass operation: Benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. New England Journal of Medicine, 1982, 307, 73–78.
11. Chesebro J. H., Fuster V., Elveback L. R., et al, Effect of dipiridamole and aspirin on late vein-graft patency after coronary bypass operations. New England Journal of Medicine, 1984, 310, 209–214.
12. Kalm M., Schrader J., Control of coronary vascular tone by nitric oxide. Circulation Research, 1990, 66, 1561–1575.
13. Green G. E., Techniques of internal mammary-coronary artery anastomosis. Journal of Thoracic and Cardiovascular Surgery, 1979, 78, 455–459.
14. Mills N. L., Bringaze W. L., Preparation of the internal mammary artery graft. Which is the best method?. Journal of Thoracic and Cardiovascular Surgery, 1989, 98, 73–79.
15. Sarabu M. R., McClung J. A., Fass A., Reed G. E., Early postoperative spasm in left internal mammary artery bypass graft. Annals of Thoracic Surgery, 1987, 44, 199–200.
16. Cartier R., Pearson P. J., Lin P. J., Schaff H. V., Time course and extent of recovery of endothelium-dependent contractions and relaxations after direct arterial injury. Journal of Thoracic and Cardiovascular Surgery, 1991, 102, 371–377.
17. Lin P. J., Pearson P. J., Cartier R., Schaff H. V., Superoxide anion mediates the endothelium-dependent contractions to serotonin by regenerated endothelium. Journal of Thoracic and Cardiovascular Surgery, 1991, 102, 378–385.
18. Doyle A. E., Fraser J. R. E., Marshall R. J., Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects. Clinical Science, 1959, 18, 441–453.
19. Egan B., Panis R., Hinderliter A., Schork N., Julius S., Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. Journal of Clinical Investigation, 1987, 80, 812–817.
20. Robinson B. F., Dobbs R. J., Bayley S., Response of forearm resistance vessels to verapamil, and sodium nitroprusside in normotensive and hypertensive men: Evidence for functional abnormality of vacular smooth muscle in primary hypertension. Clinical Science, 1982, 63, 33–42.
21. Hulthen U. L., Bolli P., Bühler F. R., Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man. British Journal of Clinical Pharmacology, 1985, 20, 62S-66S.
22. Panza J. A., Quyyumi A. A., Brush J. E., Epstein S. E., Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. New England Journal of Medicine, 1990, 323, 22–27.
23. Panza J. A., Casino P. R., Kilcoyne C. M., Quyyumi A. A., Impaired endothelium-dependent vasodilation in patients with essential hypertension: Evidence that the abnormality is not at the muscarinic receptor level. Journal of the American College of Cardiology, 1994, 23, 1610–1616.
24. Calver A., Collier J., Moncada S., Vallance P., Effect of local intra-arterial N G-monornethyl-l-arginine in patients with hypertension: nitric oxide dilator mechanism appears abnormal. Journal of Hypertension, 1992, 10, 1025–1031.
25. Myers M. L., Li G.-H., Yaghi A., McCormack D., Human internal thoracic artery reactivity to dopaminergic agents. Circulation, 1993, 88 [part 2], 110–114.
26. He G. W., Angus B., Rosenfeldt F. L., Rectavity of the canine isolated internal mammary artery, saphenous vein and coronary artery to constrictor and dilator substances. Relevance to coronary bypass graft surgery. Journal of Cardiovascular Pharmacology, 1988, 12, 12–22.
27. Kenakin T. P., Pharmacologic Analysis of Drug-receptor Interaction. Raven Press, New York, 1987.
28. Kähönen M., Mäkynen H., Arvola P., Pörsti I., Enhancement of arterial relaxation by long-term atenolol treatment in spontaneously hypertensive rats. British Journal of Pharmacology, 1994, 112, 925–933.
29. Falloon B. J., Heagerty A. M., In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension, 1994, 24, 16–23.
30. Tschudi M. R., Criscione L., Novosel D., Pfeiffer K., Lüschner T. F., Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation, 1994, 89, 2212–2218.
31. Küng C. F., Lüschner T. F., Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension, 1995, 25, 194–200.
32. Morgan K. G., Papageorgiou P., Jiang M. J., Pathophysiological role of calcium in the development of vascular smooth muscle tone. American Journal of Cardiology, 1989, 64, 3517–4017.
33. Triggle D. J., Calcium antagonists. In Cardiovascular Pharmacology, ed. Antonaccio M. Raven Press, New York, 1990, pp 107–160.
34. Opie L. H., Uklad renina-aniotensyna-aldosteron i inne proponowane obszary dzialania inhibitorów konwertazy. In Inhibitory konwertazy angiotensyny. Naukowe podstawy stosowania klinicznego. Wydawnictwo Naukowe PWN, Warszawa, 1995, pp 1–21.
35. Purdy R. E., Weber M. A., Angiotensin-II amplification of alpha-adrenergic vasoconstriction: Role of receptor reserve. Circulation Research, 1988, 63, 748–757.
36. Gohlke P., Bunning P., Unger T., Distribution and metabolism of angiotensin-I and II in the blood vessel wall. Hypertension, 1992, 20, 151–157.
37. Carretaro O. A., Angiotensin converting enzyme inhibitors and endothelial dysfunction. American Journal of Hypertension, 1995, 8, 42S-44S.
38. Berridge M. J., Inositol triphosphate and calcium signaling. Nature, 1993, 361, 315–325.
39. Flavahan N. A., Vanhoutte P. M., Endothelial cell signaling and endothelial dysfunction. American Journal of Hypertension, 1995, 8, 28S-11S.
40. Flavahan N. A., Shimokawa H., Vanhoutte P. M., Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. Journal of Physiology, 1989, 408, 549–560.
41. Liao J. K., Homcy C. J., The G proteins of the Gαi and Gαq family couple the bradykinin receptor to the release of endothelium-derived relaxin factor. Journal of Clinical Investigation, 1993, 92, 2168–2172.
42. Flavahan N. A., Atherosclerosis of lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying reduction in endothelium-derived relaxing factor/nitric oxide activity. Circulation, 1992, 85, 1927–1938.